Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies-Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce.

Julijana Asllani,Dimitrios Mitsias,George Konstantinou,Eris Mesonjesi, Fatmira Xhixha, Esmeralda Shehu,George Christoff, Katia Noleva,Michael Makris,Xenofon Aggelidis, Mirjana Turkalj,Erceg Damir,Ioana Agache,Vesna Tomic-Spiric, Rajica Stosovic,Zeynep Misirligil,Mitja Kosnik,Todor A Popov,Moises Calderon,Nikolaos G Papadopoulos

Clinical and translational allergy（2023）

引用 0|浏览28

暂无评分

摘要

AIT is safe and well tolerated in children and adolescents with respiratory allergies in real-life clinical practice. Though SCIT is more prone to AE compared to SLIT, overall severe reactions are rare and occur during build-up and early maintenance.

查看译文

关键词

allergen immunotherapy,respiratory allergies—report,allergy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要